Preview

Experimental and Clinical Gastroenterology

Advanced search

Analysis of morphological and morphometric characteristics of the mouse stomach wall after oral administration of iron oxide nanoparticles

https://doi.org/10.31146/1682-8658-ecg-244-12-186-192

Abstract

Iron oxide nanoparticles attract attention in the scientific community due to the wide range of their unique physico-chemical properties obtained during various synthesis methods. However, their effects on the body when administered orally have not been sufficiently studied. This work was aimed to study of morphological and morphometric characteristics of the gastric mucosa of laboratory mice using synthetic and biogenic iron oxide nanoparticles as a feed additive. Materials and methods. Nanoparticles of synthetic and biogenic iron origin were used in the work. The laboratory mice (n = 55) were allocated into 3 groups: 1 group of mice (n = 15) were intact animals that received standard feeding; group 2 (n = 20) fed food with synthetic nanoparticles; group 3 (n = 20) fed food with biogenic nanoparticles. The biological material (mouse stomach) was sampled on days 1, 22, and 36. Histological sections were stained with hematoxylin-eosin and Perls. Morphometric analysis of the drugs was performed in the program “ViodeoTesT - Morphology 7.0”. Results. Upon oral administration of iron oxide nanoparticles into the body, lymphohistiocytic infiltration, hemorrhages, enlargement of the gastric glands, cysts, and dystrophic changes in the cells of the columnar epithelium were detected in both groups. At the same time, foci of atrophic gastritis and pronounced foci of destruction of the gastric glands were noted in animals of group 3 on day 36. Conclusion. The entry of both synthetic and biogenic iron oxide nanoparticles into the gastrointestinal tract for 36 days causes pathological changes in the stomach tissue in the form of epithelial metaplasia with dystrophic changes in the gastric glands.

About the Authors

A. V. Kireeva
Krasnoyarsk Science Centre of the Siberian Branch of Russian Academy of Science
Russian Federation


O. A. Kolenchukova
Scientific Research Institute of Medical Problems of the North Federal Research Center Krasnoyarsk Science Centre of the Siberian Branch of Russian Academy of Science; Krasnoyarsk state agricultural university
Russian Federation


E. A. Biryukova
Scientific Research Institute of Medical Problems of the North Federal Research Center Krasnoyarsk Science Centre of the Siberian Branch of Russian Academy of Science
Russian Federation


References

1. Zhang L., Zhao D. Applications of nanoparticles for brain cancer imaging and therapy. J Biomed Nanotechnol. 2014;10(9):1713-31. doi: 10.1166/jbn.2014.1896.

2. Mittal A., Roy I., Gandhi S. Magnetic nanoparticles: an overview for biomedical applications. Magnetochemistry. 2022;8(9):107. doi: 10.3390/magnetochemistry8090107.

3. Öztürk K, Kaplan M., Çalış S. Effects of nanoparticle size, shape, and zeta potential on drug delivery.Int J Pharm. 2024;666:124799. doi: 10.1016/j.ijpharm.2024.124799.

4. Hua S. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol. 2020;11:524. doi: 10.3389/fphar.2020.00524.

5. Ghosh R., Arcot J. Fortification of foods with nano-iron: its uptake and potential toxicity: current evidence, controversies, and research gaps. Nutr Rev. 2022;80(9):1974-84. doi: 10.1093/nutrit/nuac011.

6. Voss L, Hsiao I.L., Ebisch M. et аl. The presence of iron oxide nanoparticles in the food pigment E172. Food Chem. 2020;327:127000. doi: 10.1016/j.foodchem.2020.127000.

7. Zhang Q., Wu W., Zhang J., Xia X. Eradication of Helicobacter pylori: The power of nanosized formulations. Nanomedicine. 2020;15(5):527-542. doi: 10.2217/nnm-2019-0329.

8. Zhu X., Su T., Wang S. et аl. New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer. Front Oncol. 2022;12:834934. doi: 10.3389/fonc.2022.834934.

9. Date A.A., Hanes J., Ensign L.M. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release. 2016;240:504-526. doi: 10.1016/j.jconrel.2016.06.016.

10. Maisel K., Ensign L., Reddy M. et аl. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48-57. doi: 10.1016/j.jconrel.2014.10.026.

11. Banerjee A., Qi J., Gogoi R. et аl. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176-185. doi: 10.1016/j.jconrel.2016.07.051.

12. Garcia-Fernandez J., Turiel D., Bettmer J. et аl. In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements. Nanotoxicology. 2020;14(3):388-403. doi: 10.1080/17435390.2019.1710613.

13. Egbuna C., Parmar V.K., Jeevanandam J. et al. Toxicity of nanoparticles in biomedical application: nanotoxicology. J Toxicol. 2021;9954443. doi: 10.1155/2021/9954443.

14. Stolyar S.V., Kolenchukova O.A., Boldyreva A.V. et al. Biogenic ferrihydrite nanoparticles: synthesis, properties in vitro and in vivo testing and the concentration effect. Biomedicines. 2021;9(3):323. doi: 10.3390/biomedicines9030323.

15. Mohamed E.K., Fathy M.M., Sadek N.A. et al. The effects of rutin coat on the biodistribution and toxicities of iron oxide nanoparticles in rats. J Nanopart Res. 26:49. doi: 10.1007/s11051-024-05949-w.

16. Göring J., Schwarz C., Unger E. et al. The Long-Term Impact of Polysaccharide-Coated Iron Oxide Nanoparticles on Inflammatory-Stressed Mice. J. Xenobiot. 2024;14:1711-1728. doi: 10.3390/jox14040091.

17. Vakili-Ghartavol R., Momtazi-Borojeni A.A., Vakili-Ghartavol Z. et al. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues. Artificial Cells, Nanomedicine, and Biotechnology. 2020;48(1):443-51. doi: 10.1080/21691401.2019.1709855.

18. Kireeva A.V., Kolenchukova O.A., Biryukova E.A. et al. Effect of synthetic and biogenic iron oxide nanoparticles on histopathological parameters of mouse kidneys. J Evol Biochem Phys. 2025;61:261-72. doi: 10.1134/S0022093025010211.

19. Chrishtop V.V., Mironov V.A., Prilepskii A.Y. et al. Organ-specific toxicity of magnetic iron oxide-based nanoparticles. Nanotoxicology. 2021;15(2):167-204. doi: 10.1080/17435390.2020.1842934.

20. Strugari A.F.G., Stan M.S., Gharbia S. et al. Characterization of nanoparticle intestinal transport using an in vitro co-culture model. Nanomaterials (Basel). 2018;9(1):5. doi: 10.3390/nano9010005.

21. Chamorro S., Gutiérrez L., Vaquero M.P. et al. Safety assessment of chronic oral exposure to iron oxide nanoparticles. Nanotechnology. 2015;26(20):205101. doi: 10.1088/0957-4484/26/20/205101.

22. González A., Gálvez N., Martín J. et al. Identification of the key excreted molecule by Lactobacillus fermentum related to host iron absorption. Food Chem. 2017;228:374-80. doi: 10.1016/j.foodchem.2017.02.008.

23. Skolmowska D., Głąbska D. Analysis of heme and non-heme iron intake and iron dietary sources in adolescent menstruating females in a national polish sample. Nutrients. 2019;11(5):1049. doi: 10.3390/nu11051049.

24. Skrypnik K., Bogdański P., Sobieska M. et al. Hepcidin and erythroferrone correlate with hepatic iron transporters in rats supplemented with multispecies probiotics. Molecules. 2020;25(7):1674. doi: 10.3390/molecules25071674.

25. Portilla Y., Mellid S., Paradela A. et al. Iron oxide nanoparticle coatings dictate cell outcomes despite the influence of protein coronas. ACS Appl Mater Interfaces. 2021;13(7):7924-44. doi: 10.1021/acsami.0c20066.

26. des Rieux A., Ragnarsson E.G., Gullberg E. et al. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur. J. Pharmaceut. Sci. 2005; 25(4-5):455-465. doi: 10.1016/j.ejps.2005.04.015.

27. Carr K.E., Smyth S.H., McCullough M.T. et al. Morphological aspects of interactions between microparticles and mammalian cells: intestinal uptake and onward movement. Prog Histochem Cytochem. 2012;46(4):185-252. doi: 10.1016/j.proghi.2011.11.001.

28. Wang X., Gong J., Tan W. et al. Adsorption of proteins on oral Zn2+ doped iron oxide nanoparticles in mouse stomach and in vitro: triggering nanoparticle aggregation. Nanoscale. 2020;12(44):22754-67. doi: 10.1039/d0nr06315k.

29. Wu L., Wen W., Wang X. et al. Ultrasmall iron oxide nanoparticles cause significant toxicity by specifically inducing acute oxidative stress to multiple organs. Part Fibre Toxicol. 2022;19:24. doi: 10.1186/s12989-022-00465-y.

30. Raĭkher Yu.L., Stepanov V.I., Stolyar S.V. et al. Magnetic properties of biomineral particles produced by bacteria Klebsiella oxytoca. Physics of the Solid State. 2010;52:298-305. doi: 10.1134/S1063783410020125.

31. Vandebriel R.J., Vermeulen J.P., van Engelen L.B. et al. The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo. Part Fibre Toxicol. 2018;15:9. doi: 10.1186/s12989-018-0245-5.


Review

For citations:


Kireeva A.V., Kolenchukova O.A., Biryukova E.A. Analysis of morphological and morphometric characteristics of the mouse stomach wall after oral administration of iron oxide nanoparticles. Experimental and Clinical Gastroenterology. 2025;(12):186-192. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-244-12-186-192

Views: 408

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)